Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis

BACKGROUND: Severe eosinophilic asthma (SEA) in the presence of chronic rhinosinusitis with nasal polyps (CRSwNP) indicates the presence of a more extensive eosinophilic inflammation. Post-hoc analyses from a pivotal clinical trial have demonstrated the enhanced efficacy of benralizumab on asthma ou...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Amato, Maria, Menzella, Francesco, Altieri, Elena, Bargagli, Elena, Bracciale, Pietro, Brussino, Luisa, Caiaffa, Maria Filomena, Canonica, Giorgio Walter, Caruso, Cristiano, Centanni, Stefano, De Michele, Fausto, Di Marco, Fabiano, Pastorello, Elide Anna, Pelaia, Girolamo, Rogliani, Paola, Romagnoli, Micaela, Schino, Pietro, Senna, Gianenrico, Vultaggio, Alessandra, Ori, Alessandra, Simoni, Lucia, Boarino, Silvia, Vitiello, Gianfranco, Aliani, Maria, Del Giacco, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234857/
https://www.ncbi.nlm.nih.gov/pubmed/35769575
http://dx.doi.org/10.3389/falgy.2022.881218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234857/
https://www.ncbi.nlm.nih.gov/pubmed/35769575
http://dx.doi.org/10.3389/falgy.2022.881218

Ejemplares similares